传奇生物将在2025ASCO、EHA和ASGCT上公布CARVYKTI®治疗肿瘤和血液病新进展,包括长期疗效、生存期改善及实体瘤研究初步结果。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.